Publications from the Centre for Immuno-Oncology
UK cancer vaccine advance - Recognising and realising opportunities.
Craddock C. et al, (2025), Cambridge prisms. Precision medicine, 3
Independent SAGE as an example of effective public dialogue on scientific research.
Greenhalgh T. et al, (2024), Nature protocols
An eDElphi STudy to defINe and risk-stratify ImmunosupprESsion: Protocol for the DESTINIES Study (Preprint)
Leston M. et al, (2024), JMIR Research Protocols
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).
Starkey T. et al, (2023), Scientific reports, 13
Systematic review and meta-analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID-19 in immunocompromised patients.
Suribhatla R. et al, (2023), British journal of haematology, 201, 813 - 823
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research.
Fittall M. et al, (2023), British journal of cancer, 128, 1977 - 1980
Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team.
Appanna N. et al, (2023), International journal of cancer, 152, 1275 - 1277
Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review.
Al Hajji Y. et al, (2022), British journal of cancer, 127, 1827 - 1836
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.
Lee LYW. et al, (2022), European journal of cancer (Oxford, England : 1990), 175, 1 - 10
Machine learning for determining lateral flow device results for testing of SARS-CoV-2 infection in asymptomatic populations.
LFD AI Consortium. Electronic address: a.beggs@bham.ac.uk None. and LFD AI Consortium None., (2022), Cell reports. Medicine, 3
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.
Lee LYW. et al, (2022), The Lancet. Oncology, 23, 748 - 757
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
Várnai C. et al, (2022), JAMA Network Open, 5, e220130 - e220130
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission
Lee LYW. et al, (2022), Clinical Infectious Diseases, 74, 407 - 415
COVID-19 in children with haematological malignancies.
Millen GC. et al, (2022), Archives of disease in childhood, 107, 186 - 188
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
Booth S. et al, (2022), British journal of haematology, 196, 892 - 901
Letter to the editor in response to a letter by Deeks regarding Peto T; UK COVID-19 lateral flow oversight team: COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay.
Lee LYW. and Peto TE., (2021), EClinicalMedicine, 38
Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project.
Millen GC. et al, (2021), British journal of cancer, 124, 754 - 759